Skip to main content

Lazard, Inc.

For the period ended Jun 30, 2026. Filed Jul 28, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 28, 2026

LAZ$39.54+3.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

During the three months ended June 30, 2026, certain directors and officers of the Company adopted a “Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K, as set forth in the table below:

Trading Arrangement
Action · Date · Rule 10b5-1 (a) · Non-Rule 10b5-1 (b) · Total Shares to be Sold (c) · Expiration Date
Peter R. Orszag (Chief Executive Officer and Chairman)AdoptMay 22, 2026x84,103March 31, 2027
Tracy Farr (Chief Financial Officer)AdoptJune 8, 2026x3,476 (d)March 31, 2027
Christopher Hogbin (Chief Executive Officer of Lazard Asset Management)AdoptMay 22, 2026x10,228 (d)March 31, 2027
Christian A. Weideman (General Counsel)AdoptMay 22, 2026x14,169March 31, 2027

(a)Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

(b)Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

(c)Represents the maximum number of shares that may be sold pursuant to the Rule 10b5-1 trading arrangement. The actual number of shares sold will be dependent on the terms of, and the satisfaction of the conditions as set forth in, the written plan. Sales of the shares pursuant to the plan, together with any incremental sales to the Company, are intended to cover estimated taxes and other personal expenditures.

(d)The Rule 10b5-1 trading arrangement includes the sale of shares to be received upon future vesting of certain outstanding equity awards, net of any shares withheld by us to satisfy applicable taxes. The number of shares to be withheld, and thus the exact number of shares to be sold pursuant to the Rule 10b5-1 trading arrangement, can only be determined upon the occurrence of the future vesting events.

During the three months ended June 30, 2026, no other directors or and no other officers of the Company entered into, modified orterminated, contracts, instructions or written plans for the sale or purchase of Lazard securities that were intended to satisfy the affirmative defense conditions of Rule 10b5-1 or that constituted non-Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K of the Exchange Act).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.